华东师大科学家六年半攻关,给细胞“喝红酒”调控肿瘤免疫治疗 Resveratrol-triggered switches maximize cancer immunotherapy
Resveratrol-triggered genetic switches, which can control in vivo tumor-targeted chimeric antigen receptor T-cell (CAR T) therapy, have been developed by ECNU researchers, who demonstrated that the new tools enabled maximized in vivo immunotherapeutic efficacy while minimizing toxicity.Our group has created the first [resveratrol]-controlled genetic switch enabling us to control CAR T-cell ther...
08/20/2021